Select language
English
English German Spanish Italian French

General

Lupin Neurosciences is committed to working with Healthcare Professionals to develop science-based solutions that stretch beyond access to lifechanging treatment options to optimize patient care in underserved neurological diseases.
Portfolio
  • NaMuscla®
    • Pipeline
  • Overview
    • Publications
  • 2023 Congresses
  • 2024 Congress
    • General
  • Medical Inquiries & Adverse Event Reporting
  • Transparency Reporting
    • EAN: 9th Congress of the European Academy of Neurology, Budapest, Hungary, 1-4 July 2023
    Myotonic Dystrophy

    A-23-06375 EPO-392
    RevEal the burdeN on daily life for myotonic dyStrophy patients due to myotoniA: the ENSA survey
    Sansone V, Ashley EJ , Montagnese F, Gagnon C, Nowak U, Dang U, Turner C, Nikolenko N, Tard C, Zozulya-Weidenfeller A.
    EAN ENSA Abstract
    EAN ENSA Poster

    Non-Dystrophic Myotonia

    A-23-06846/EPO-411
    Recommendations of an expert group for cardiac assessment of non-dystrophic myotonic adult patients treated with mexiletine
    Vicart S, Wahbi K, Duchateau J, Sellal JM, Deharo JC,  Bassez G, Salort-Campana E,  Labombarda F.
    EAN Cardimex Abstract
    EAN Cardimex Poster

    A-23-06885/EPO-410:
    Validity and Reliability of a New Clinical Myotonia Rating Scale for Non-Dystrophic Myotonia
    Vicart S,  Franques J, Bouhour F,  Magot A, Péréon Y, Sacconi S, Nadaj-Paklezaf A, Behin A, Payan C, Fontaine B .
    EAN CMRS Abstract
    EAN CMRS Poster